1,148
Views
9
CrossRef citations to date
0
Altmetric
Author's View

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis

, , , , , & show all
Article: e1120399 | Received 09 Nov 2015, Accepted 09 Nov 2015, Published online: 19 Apr 2016

Figures & data

Figure 1. Reduced tumor growth and metastasis as a consequence of impaired immune suppression in CD81KO mice. In wild-type mice, primary tumors grow and recruit immune suppressor T regulatory cells (Tregs), and myeloid-derived suppressor cells (MDSCs). These suppressor cells secrete IL-10 and inhibit the antitumor T effector (Teff) response allowing tumors to grow and metastasize to the lungs (left panel). In contrast, Tregs and MDSCs still accumulate in CD81KO mice, but are impaired at suppressing Teff cells, thereby reducing tumor growth and metastasis (right panel).

Figure 1. Reduced tumor growth and metastasis as a consequence of impaired immune suppression in CD81KO mice. In wild-type mice, primary tumors grow and recruit immune suppressor T regulatory cells (Tregs), and myeloid-derived suppressor cells (MDSCs). These suppressor cells secrete IL-10 and inhibit the antitumor T effector (Teff) response allowing tumors to grow and metastasize to the lungs (left panel). In contrast, Tregs and MDSCs still accumulate in CD81KO mice, but are impaired at suppressing Teff cells, thereby reducing tumor growth and metastasis (right panel).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.